SCHEMBL28390366

SCHEMBL28390366

O=C(NN=Cc1ccc(C(=O)Nc2ccc(F)cc2)cc1)c1ccncc1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.74
KMT2A Q03164 8/20 0.73
MEN1 O00255 7/20 0.73
POLB P06746 4/20 0.73
MAPT P10636 3/20 0.73
TDP1 Q9NUW8 3/20 0.73
L3MBTL1 Q9Y468 2/20 0.73
ALDH1A1 P00352 2/20 0.73
KDM4E B2RXH2 1/20 0.73
RECQL P46063 1/20 0.73
SMN1; SMN2 Q16637 4/20 0.69
NPC1 O15118 3/20 0.69
CTDSP1 Q9GZU7 1/20 0.65
LMNA P02545 1/20 0.64
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2D6 P10635 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
ASF1A Q9Y294 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28390365 1.00 RAB9A (0.74) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL12443128 0.91 SMN1; SMN2 (0.79) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL28888709 0.89 KMT2A (0.93) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL28389907 0.89 MAPT (0.93) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL28393986 0.89 MAPT (0.93) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL28395587 0.89 MAPT (0.72) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL28395216 0.89 MAPT (0.72) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL28390518 0.89 KMT2A (0.93) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL28392610 0.88 MAPT (0.71) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL28392611 0.88 MAPT (0.71) RAB9AKMT2AMEN1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116464-B (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2022-09-13 CN claimed
CN-111116464-A (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2020-05-08 CN claimed
CN-111116464-B (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2022-09-13 CN disclosed
CN-111116464-A (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2020-05-08 CN disclosed